Beta Drugs fundamental analysis
BETA
1412.4
32.70 (2.37%)Last updated on 9 Feb, 2026 | 09:56 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Beta Drugs Fundamentals
P/E Ratio
32.83
P/B Ratio
7.07
Div. Yield
0
Sector P/E
63.34
Sector P/B
1.32
Sec. Div. Yield
0.58
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 32.83, compared to the sector average of 63.34. Its P/B Ratio stands at 7.07, while the sector’s is 1.32. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
